Skip to content
MedsAcross

Medicine

Primaquine 15 mg tablet

Primaquine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Primaquine 15 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25° C (77° F), excursions permitted to 15° - 30° C (59° - 86° F).

Key facts

Active ingredient (INN)
Primaquine
Brand
Sold under the generic name
Strength
15 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 14 tablets and 4 more
Manufacturers
Unichem LaboratoriesIndiaIngenus PharmaceuticalsPD-Rx PharmaceuticalsAvKARESanofi-Aventis
Origin register
US FDA, United States
Storage
Store at 25° C (77° F), excursions permitted to 15° - 30° C (59° - 86° F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
P01BA03 Primaquine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 April 2011
Identifiers
RxCUI 904170DailyMed set ID 0c8c2bc6-428b-40b6-8114-6df80290878d, 3f16166d-678e-51aa-e054-00144ff88e88, 09531382-2e06-4164-a7e1-169a1488788a +2NDC 76385-102, 43063-721, 50742-191 +2Application ANDA204476, ANDA206043, NDA008316

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle76385-102-01Unichem LaboratoriesIndia1 August 2014
100 tablet, film coated in 1 bottle, plastic50742-191-01Ingenus Pharmaceuticals23 January 2018
500 tablet, film coated in 1 bottle, plastic50742-191-05Ingenus Pharmaceuticals23 January 2018
100 tablet, film coated in 1 bottle0024-1596-01Sanofi-Aventis15 April 2011
100 tablet, film coated in 1 bottle42291-510-01AvKARE21 February 2019
14 tablet in 1 bottle, plastic43063-721-14PD-Rx Pharmaceuticals17 October 2016
28 tablet in 1 bottle, plastic43063-721-28PD-Rx Pharmaceuticals17 October 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 23 January 1952Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Primaquine is an antimalarial indicated for the radical cure (prevention of relapse) of vivax malaria. It is available as tablets for oral use. MedsAcross supplies Primaquine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Primaquine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Primaquine 15 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.